Through a current systematic review and network meta-analysis based on 50 RCTs including 15,494 participants, we report the best available evidence comparing the efficacy and safety among different types of non-insulin anti-diabetic agents as an add-on to pre-existing insulin therapy in patients with inadequately controlled T2DM. Here, INS is linked to type 2 diabetes mellitus.